These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7667607)

  • 81. Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy.
    Yavuz D; Topçu G; Ozener C; Akalin S; Sirikçi O
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):520-4. PubMed ID: 16268803
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Size and charge heterogeneity of pituitary and plasma prolactin in the male rat.
    Briski KP; Swanson GN; Sylvester PW
    Neuroendocrinology; 1996 May; 63(5):437-45. PubMed ID: 8738581
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Macroprolactinemia revisited: a study on 106 patients.
    Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
    J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Human prolactin heterogeneity in pituitary effluent blood.
    Jordan RM; Tresp NM; Kohler PO
    Horm Metab Res; 1985 Nov; 17(11):598-601. PubMed ID: 4077023
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia.
    Cattaneo F; Kappeler D; Müller B
    Swiss Med Wkly; 2001 Mar; 131(9-10):122-6. PubMed ID: 11416967
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group.
    Webster J; Piscitelli G; Polli A; D'Alberton A; Falsetti L; Ferrari C; Fioretti P; Giordano G; L'Hermite M; Ciccarelli E
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):534-41. PubMed ID: 1286524
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hyperprolactinaemia in patients with systemic lupus erythematosus.
    Moszkorzová L; Lacinová Z; Marek J; Musilová L; Dohnalová A; Dostál C
    Clin Exp Rheumatol; 2002; 20(6):807-12. PubMed ID: 12508772
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Persistence of large molecular weight prolactin secretion during pregnancy in women with macroprolactinemia and its presence in fetal cord blood.
    Jackson RD; Wortsman J; Malarkey WB
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1046-50. PubMed ID: 2723025
    [TBL] [Abstract][Full Text] [Related]  

  • 90. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.
    St-Jean E; Blain F; Comtois R
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):305-9. PubMed ID: 8729527
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An evaluation of patients with hyperprolactinemia: have dynamic tests had their day?
    Di Sarno A; Rota F; Auriemma R; De Martino MC; Lombardi G; Colao A
    J Endocrinol Invest; 2003; 26(7 Suppl):39-47. PubMed ID: 14604065
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [The combined stimulation test sulpiride-TRH in the investigation of prolactin secretion].
    Miras-Mirakian P; Claustrat F; Dechaud H; Pugeat M
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(4):419-23. PubMed ID: 1624729
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity.
    Jacobi AM; Rohde W; Ventz M; Riemekasten G; Burmester GR; Hiepe F
    Lupus; 2001; 10(8):554-61. PubMed ID: 11530997
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Determination of ultrafilterable prolactin: elimination of macroprolactin interference with a monomeric prolactin-selective sample pretreatment.
    Quinn AM; Rubinas TC; Garbincius CJ; Holmes EW
    Arch Pathol Lab Med; 2006 Dec; 130(12):1807-12. PubMed ID: 17149954
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: should it be treated during therapy for infertility?
    Nawroth F
    Reprod Biomed Online; 2005 Nov; 11(5):581-8. PubMed ID: 16409707
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis.
    Berczi I; Cosby H; Hunter T; Baragar F; McNeilly AS; Friesen HG
    Br J Rheumatol; 1987 Dec; 26(6):433-6. PubMed ID: 3690137
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Macroprolactinemia, a variety of hyperprolactinemia. Apropos of 5 cases].
    Recchi V; Hieronimus S; Creisson G; Freychet P; Morange I; Canivet B
    Rev Med Interne; 1997; 18(4):320-3. PubMed ID: 9161560
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases.
    Zhu J; Tang Y; Lv C; Cong H; Liu J; Zhao S; Wang Y; Zhang K; Yu W; Cai Q; Ma R; Wang J
    Front Genet; 2023; 14():1018668. PubMed ID: 36845388
    [No Abstract]   [Full Text] [Related]  

  • 99. Hyperprolactinemia and insulin resistance.
    Gierach M; Bruska-Sikorska M; Rojek M; Junik R
    Endokrynol Pol; 2022; 73(6):959-967. PubMed ID: 36621922
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prolactin immunoassay: does the high-dose hook effect still exist?
    Raverot V; Perrin P; Chanson P; Jouanneau E; Brue T; Raverot G
    Pituitary; 2022 Aug; 25(4):653-657. PubMed ID: 35793045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.